Hosted on MSN1mon
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (NASDAQ:SNY ... switch of Cialis tablets from a prescription-only medicine to an over-the-counter product. The company added that it is finalizing the clinical and regulatory work ...
Drug Store News1mon
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling ... and will feature a full-service pharmacy with limited over-the-counter products available for purchase. Walgreens’ three core segments—U.S ...
Hosted on MSN11mon
Sanofi reportedly lining up banks for consumer products spinoff
Sanofi’s consumer unit markets a number of well-known over-the-counter products, including Zantac 360, Allegra, Nasacort, Selsun Blue, Gold Bond and Aspercreme. Sanofi would be the latest Big ...
pharmaphorum2y
GSK, Sanofi and Haleon 'facing billions of dollars in Zantac liability'
Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...
OTC Consumer Health Market Positioned For Accelerated Growth With Johnson&Johnson, Abbott Laboratories, Sanofi, Unilever
OTC Consumer Health Market Growth 2025 BURLINGAME, CA, UNITED STATES, March 11, 2025 /EINPresswire / --The Global OTC Consumer Health ...
Yahoo Finance1mon
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
The medicine is so popular that most paracetamol products ... the-counter vitamins, minerals, and supplements market. Given Opella’s significant economic contribution to France, Sanofi’s ...